ask="48.00"
ask_size="200"
average_daily_volume="974540"
bid="35.00"
bid_size="100"
book_value="4.05"
change="+2.62"
change_from_200_day_moving_average="-5.96"
change_from_50_day_moving_average="-3.01"
change_from_52_week_high="-13.87"
change_From_52_week_low="10.03"
change_in_percent="+6.78%"
close="41.28"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.76"
ex_dividend_date="N/A"
float_shares="85928000"
high="41.94"
high_52_weeks="55.15"
last_trade_date="1/4/2017"
last_trade_price="41.28"
last_trade_size="75976"
last_trade_time="4:00pm"
low="38.61"
low_52_weeks="31.25"
market_capitalization="3.59B"
moving_average_200_day="47.24"
moving_average_50_day="44.29"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="68.00"
open="38.80"
pe_ratio="N/A"
peg_ratio="0.63"
percent_change_from_200_day_moving_average="-12.62%"
percent_change_from_50_day_moving_average="-6.81%"
percent_change_from_52_week_high="-25.15%"
percent_change_from_52_week_low="+32.10%"
previous_close="38.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.55"
price_per_sales="223.90"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.97"
stock_exchange="NMS"
symbol="NBIX"
volume="1568670"
weeks_range_52="31.25 - 55.15"
